In vitro activity of fidaxomicin against nontuberculosis mycobacteria.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of medical microbiology"
DOI: 10.1099/jmm.0.001549
Abstract: Introduction. Nontuberculous mycobacteria (NTM) infections are increasing worldwide and are relatively resistant to many of the first- and second-line drugs to treat tuberculosis. Macrolide antibiotics, such as clarithromycin and azithromycin, are the key drugs for… read more here.
Keywords: fidaxomicin; reference strains; activity; vitro activity ... See more keywords
Fidaxomicin-Associated Hypersensitivity Reactions: Report of a Morbilliform Drug Eruption.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of pharmacy practice"
DOI: 10.1177/08971900221078780
Abstract: PURPOSE We report a probable case of morbilliform drug eruption secondary to fidaxomicin in a patient with Clostridioides difficile infection (CDI). SUMMARY A 62-year-old female presented to our institution's emergency department (ED) with symptoms consistent… read more here.
Keywords: morbilliform drug; fidaxomicin; patient; drug eruption ... See more keywords